Convergence of biomaterials and immunology: a technology platform for delayed burst release of vaccines. A large challenge in vaccination, particularly in wildlife such as for the growing problem of Chlamydia in koalas, is to provide the necessary booster shots. This project will develop implants that will be inserted under the skin at the time of the first shot, and will spontaneously burst later to release the booster shot to provide protection.
Engineering Articular Cartilage with Zonal Structure and Function. This project addresses the National Research Priority of Promoting and Maintaining Good Health and specifically the Priority Goal of Ageing well, ageing productively. Osteoarthritis, the most common cartilage-related disease, affects nearly 1.4 million Australians, resulting in 2 in 1000 Australians undergoing total joint replacement, annually. The incidence and impact of cartilage damage on the Australian health and economy is e ....Engineering Articular Cartilage with Zonal Structure and Function. This project addresses the National Research Priority of Promoting and Maintaining Good Health and specifically the Priority Goal of Ageing well, ageing productively. Osteoarthritis, the most common cartilage-related disease, affects nearly 1.4 million Australians, resulting in 2 in 1000 Australians undergoing total joint replacement, annually. The incidence and impact of cartilage damage on the Australian health and economy is expected to increase with the ageing population. This work leads to the development of a novel cartilage engineering technology platform that addresses Frontier Technologies and will thus provide the foundation for translation of this technology to the international marketplace. Read moreRead less
Molecularly engineered cell-instructive hydrogels for enhanced tissue regeneration. The outcomes of this project will be relevant to range of wounds, including burns, bed-sores, and diabetic and venous ulcers. Clearly, innovation in wound healing is urgently required as the treatment of wounds represents a significant challenge at all levels of our society, in terms of cost (physical, emotional and financial) to patients, the economy and to the wider community. Despite this obvious and overwhelm ....Molecularly engineered cell-instructive hydrogels for enhanced tissue regeneration. The outcomes of this project will be relevant to range of wounds, including burns, bed-sores, and diabetic and venous ulcers. Clearly, innovation in wound healing is urgently required as the treatment of wounds represents a significant challenge at all levels of our society, in terms of cost (physical, emotional and financial) to patients, the economy and to the wider community. Despite this obvious and overwhelming need, research in wound healing is relatively under-developed and has yet to adopt modern biotechnology and biomaterials approaches. This project is therefore directed at generating cost-effective frontier wound dressing technologies that accelerate wound repair.Read moreRead less
Tissue Engineering the Meniscus: Combining Novel Biomimetic Hybrid Scaffolds with Adult Stem Cells. Development of a meniscal implant ex vivo will provide significant health and economic benefits, given that worldwide, millions of people annually suffer from meniscus damage or loss. We believe that a tissue engineered meniscus, composed of a novel biomimetic scaffold which guides the differentiation of mesenchymal stem cells in a novel bioreactor will provide a solution to the problem of donor ....Tissue Engineering the Meniscus: Combining Novel Biomimetic Hybrid Scaffolds with Adult Stem Cells. Development of a meniscal implant ex vivo will provide significant health and economic benefits, given that worldwide, millions of people annually suffer from meniscus damage or loss. We believe that a tissue engineered meniscus, composed of a novel biomimetic scaffold which guides the differentiation of mesenchymal stem cells in a novel bioreactor will provide a solution to the problem of donor scarcity in meniscal repair. Success in this project will lead directly to large-animal studies and clinical trials. The training of four early careeer researchers involved in this project will also be of significant benefit to the Australian Tissue Engineering and Biomaterials community.Read moreRead less
Improving immune response to vaccines by selective targeting of epithelial regions with the Nanopatch. Vaccination protects us from infections like measles and flu. In principle, it could protect us from all diseases, even from skin cancer and arthritis. In practice, however, vaccines to diseases like cancer have largely proved ineffective. One problem is that we don't really understand how the body's immune system responds to vaccination. Our aim, therefore, is to investigate changes in the imm ....Improving immune response to vaccines by selective targeting of epithelial regions with the Nanopatch. Vaccination protects us from infections like measles and flu. In principle, it could protect us from all diseases, even from skin cancer and arthritis. In practice, however, vaccines to diseases like cancer have largely proved ineffective. One problem is that we don't really understand how the body's immune system responds to vaccination. Our aim, therefore, is to investigate changes in the immune system when a vaccine enters the skin, as might happen by injection. Experimenting with laboratory mice and a special vaccine-injecting Nanopatch that is attached to each mouse's ear, we are starting to understand how a vaccine affects the immune cells in the skin. In the future we plan to apply this knowledge to improve vaccination in people.Read moreRead less
Optimising the body's immune response with a Nanopatch that delivers biomolecules to the skin. The team is developing a new improved way to vaccinate against deadly infectious diseases such as influenza and malaria. They believe their Nanopatch technology will boost the power of seasonal influenza vaccination and could even solve vaccine shortages in an influenza pandemic. This is because the Nanopatch needs much less vaccine per person than a conventional syringe. They also predict that vaccine ....Optimising the body's immune response with a Nanopatch that delivers biomolecules to the skin. The team is developing a new improved way to vaccinate against deadly infectious diseases such as influenza and malaria. They believe their Nanopatch technology will boost the power of seasonal influenza vaccination and could even solve vaccine shortages in an influenza pandemic. This is because the Nanopatch needs much less vaccine per person than a conventional syringe. They also predict that vaccines delivered with a Nanopatch will require less refrigeration than conventional vaccines and can be safely administered by individuals without medical training, making the benefits of vaccination accessible to more people more cheaply, even in remote areas.Read moreRead less
Mastering the Microenvironment - Integrated, functional, biosynthetic scaffolds for tissue engineering. Organ transplantation is available to only the lucky few, with, for example, less than 3000 of Australia's annual 30,000 patients suffering end-stage renal failure receiving transplants. Tissue engineering of soft, functional tissues using in vitro and/or in vivo methods offers the potential to replace missing or non-functioning tissues, such as liver, pancreas, lung, heart, fat and muscle, wi ....Mastering the Microenvironment - Integrated, functional, biosynthetic scaffolds for tissue engineering. Organ transplantation is available to only the lucky few, with, for example, less than 3000 of Australia's annual 30,000 patients suffering end-stage renal failure receiving transplants. Tissue engineering of soft, functional tissues using in vitro and/or in vivo methods offers the potential to replace missing or non-functioning tissues, such as liver, pancreas, lung, heart, fat and muscle, with newly created tissue. This project will deliver integrated, functional polymeric scaffolds for organ replacement. Over 12 higher degree candidates and one research associate will be trained in the field of tissue engineering, representing a significant benefit to the Australian scientific community.Read moreRead less
Controlling the adhesome to regulate cell fate on biomaterials. Mesenchymal stem cell-based tissue engineering practices are hampered worldwide by the lack of appreciation and understanding of the matrix-mediated cues that must be provided during adhesion and spreading to drive cells to definitive tissue end points. This project will address these knowledge deficiencies by combining high throughput array technologies, a set of tailorable self-assembling biomaterials and real-time biosensors to r ....Controlling the adhesome to regulate cell fate on biomaterials. Mesenchymal stem cell-based tissue engineering practices are hampered worldwide by the lack of appreciation and understanding of the matrix-mediated cues that must be provided during adhesion and spreading to drive cells to definitive tissue end points. This project will address these knowledge deficiencies by combining high throughput array technologies, a set of tailorable self-assembling biomaterials and real-time biosensors to rapidly, at high resolution, elucidate how mechanotransductive cues determine the fate choice of mesenchymal stem cells, and furthermore, how to manipulate them with smart biomaterial design to achieve desired outcomes for tissue engineering. Read moreRead less
Micro-nanoprojection patches for minimally-invasive and targeted delivery of genes and drugs to skin cells: from concept to technology platform. This project will address key science questions on the recently patented micro-nanoprojections patch, establishing it in Australia as a world leading technology in the rapidly growing and important field of gene and drug delivery. Unique internationally-competitive science outcoumes and research training will be generated at the interfaces between bioen ....Micro-nanoprojection patches for minimally-invasive and targeted delivery of genes and drugs to skin cells: from concept to technology platform. This project will address key science questions on the recently patented micro-nanoprojections patch, establishing it in Australia as a world leading technology in the rapidly growing and important field of gene and drug delivery. Unique internationally-competitive science outcoumes and research training will be generated at the interfaces between bioengineering, nanotechnology, pharmaceutical science and immunology. Ultimately, the project will allow improved treatment of major diseases (e.g. vaccination and immunotherapy of asthma). Achieving these health benefits by commercial pathways is expected to benefit the Australian community and emerging Biotechnology industry-creating highly valued career opportunities for Australians.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE130100986
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
An innovative platform using non-coding ribonucleic acids (RNAs) to control stem cell differentiation outcomes. It is difficult to control the tissue type that stem cells will form when combined with biomaterials, as the outcome is influenced by the 'stiffness' of the surface to which the stem cells attach. This project will determine how non-coding ribonucleic acids (RNAs) control stem cell behaviours and use this information to direct stem cell differentiation outcomes.